• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY WALLFLEX¿ ESOPHAGEAL; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY WALLFLEX¿ ESOPHAGEAL; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00516730
Device Problems Occlusion Within Device (1423); Difficult to Remove (1528)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/11/2015
Event Type  Injury  
Event Description
It was reported to boston scientific corporation that a fully covered wallflex¿ esophageal stent was implanted in the esophagus during an esophagogastroduodenoscopy (egd) procedure performed on (b)(6) 2015.According to the complainant, the physician attempted to remove the fully covered wallflex¿ esophageal stent during a planned stent removal procedure performed on (b)(6) 2015.During the stent removal procedure, the physician noted that the stent had become occluded due to tissue ingrowth.The physician was unable to remove the fully covered wallflex¿ esophageal stent.A different wallflex¿ esophageal stent was placed inside the previously implanted stent in order to allow the tissue ingrowth to necrose.On (b)(6) 2015, the physician removed the second stent and observed the initial fully covered wallflex¿ esophageal stent.The physician stated that the tissue ingrowth had necrosed and had begun sloughing off.The fully covered wallflex¿ esophageal stent was successfully removed on (b)(6) 2015.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be fine.
 
Manufacturer Narrative
The complainant was unable to provide the device lot number.Therefore, the manufacture and expiration dates are unknown.It was reported the device was not used past its expiry date.(b)(4).The device has been received for analysis; however the evaluation has not been completed.Therefore, the cause of the reported malfunction has not been determined.Upon completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Manufacturer Narrative
A fully deployed wallflex esophageal fully covered stent was returned for analysis.Visual examination of the returned device noted that the stent had numerous holes smaller than 1.0 mm in diameter in the silicone coating towards the proximal end of the stent, which is within specification for the device.A labeling review was performed and from the information available, this device was used in a manner inconsistent with the labeled indications.The dfu states; ¿warning: stent is considered to be a permanent device.Once stent placement is permanently achieved, stent removal or repositioning is not recommended.¿ the stent was removed from the patient two weeks after the procedure and was returned for analysis.Therefore, the most probable root cause classification is user/use error.
 
Event Description
It was reported to boston scientific corporation that a fully covered wallflex¿ esophageal stent was implanted in the esophagus during an esophagogastroduodenoscopy (egd) procedure performed on (b)(6) 2015.According to the complainant, the physician attempted to remove the fully covered wallflex¿ esophageal stent during a planned stent removal procedure performed on (b)(6) 2015.During the stent removal procedure, the physician noted that the stent had become occluded due to tissue ingrowth.The physician was unable to remove the fully covered wallflex¿ esophageal stent.A different wallflex¿ esophageal stent was placed inside the previously implanted stent in order to allow the tissue ingrowth to necrose.On (b)(6) 2015, the physician removed the second stent and observed the initial fully covered wallflex¿ esophageal stent.The physician stated that the tissue ingrowth had necrosed and had begun sloughing off.The fully covered wallflex¿ esophageal stent was successfully removed on (b)(6) 2015.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WALLFLEX¿ ESOPHAGEAL
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
ballybrit business park
galway
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
ballybrit business park
galway
Manufacturer Contact
nancy cutino
100 boston scientific way
marlborough, MA 01752
5086834000
MDR Report Key4927754
MDR Text Key6010777
Report Number3005099803-2015-02060
Device Sequence Number1
Product Code ESW
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K091510
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative,company representative
Reporter Occupation Other
Type of Report Initial
Report Date 06/25/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/21/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Physician
Device Model NumberM00516730
Device Catalogue Number1673
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/08/2015
Is the Reporter a Health Professional? No
Date Manufacturer Received08/31/2015
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age60 YR
-
-